EUVIMEDEUVIMED entdecken
Crossref

Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations

Jyoti Sharma, Raj Kaushal

Applied Organometallic Chemistry · 2026-12 · 40 (12)

DOI: 10.1002/aoc.70695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Organometallic Chemistry, online erschienen am 20.11.2026. Verfasst von Jyoti Sharma und 1 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The design of multitargeted metal‐centred therapeutics presents an attractive approach to concurrently addressing different pathophysiological pathways involved in diabetes. In the current work, new series of oxovanadium(V) complexes [VO (L I‐V ) 2 Cl 3 ] containing biologically active pyrazole‐chalcone ligands L I‐V where L I = (1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(m‐tolyl)prop‐2‐en‐1‐one), L II = (3‐(2,4‐dichlorophenyl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)prop‐2‐en‐1‐one), L III = (1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(3‐nitrophenyl) prop‐2‐en‐1‐one), L IV = (3‐(1H‐indol‐5‐yl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl) prop‐2‐en‐1‐one) and L V = (3‐(4‐hydroxyphenyl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)prop‐2‐en‐1‐one) have been rationally designed, synthesised and fully studied to be potentially used as antidiabetic agents (J1–J5). All synthesised complexes were characterised by physio analytical analysis (EDS, molar conductivity as well as chlorine estimation) and various spectroscopic techniques viz . UV‐Vis, FTIR, 1 H‐NMR, HRMS ion fragmentation mass study to confirm the successful formation of oxovanadium(V) coordination complexes. In this series, complex J3 showed the best inhibition of α‐glucosidase (IC 50 = 14.56 ± 1.6 μM) that far exceeds acarbose as a reference drug while it was also recorded complex J1 presented greater activity on α‐amylase inhibitory effects (IC 50 = 94.26 ± 1.3 μM) in accordance with standard inhibitors modes. Antioxidant evaluation also showed potential DPPH radical scavenging effect including complex J5 being the most potent antioxidant (IC 50 = 10.20 ± 1.4 μg/mL) confirming that a portion of its biological activity might be mediated through its complementary antioxidant role in combating oxidative stress linked to diabetes. Molecular docking revealed strong binding of complexes towards α‐glucosidase and α‐amylase consistent with their inhibitory activities, while DFT elucidated their electronic structures and structure activity relationship and further ADMET analysis indicated favourable drug likeness with moderate oral bioavailability despite inherent physiochemical limitations of metal complexes.

Zitieren

APA

Sharma, J., & Kaushal, R. (2026). Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations. Applied Organometallic Chemistry, 40(12). https://doi.org/10.1002/aoc.70695

Vancouver

Sharma J, Kaushal R. Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations. Applied Organometallic Chemistry. 2026;40(12). doi:10.1002/aoc.70695

BibTeX
@article{Sharma2026,
  author = {Sharma, Jyoti and Kaushal, Raj},
  title = {Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations},
  journal = {Applied Organometallic Chemistry},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1002/aoc.70695}
}
Kostenlos starten →